0000899243-19-024005.txt : 20190920
0000899243-19-024005.hdr.sgml : 20190920
20190920173140
ACCESSION NUMBER: 0000899243-19-024005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190919
FILED AS OF DATE: 20190920
DATE AS OF CHANGE: 20190920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lee June
CENTRAL INDEX KEY: 0001696493
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37609
FILM NUMBER: 191105514
MAIL ADDRESS:
STREET 1: C/O MYOKARDIA, INC.
STREET 2: 333 ALLERTON AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MyoKardia Inc
CENTRAL INDEX KEY: 0001552451
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 455500552
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-741-0900
MAIL ADDRESS:
STREET 1: 333 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-09-19
0
0001552451
MyoKardia Inc
MYOK
0001696493
Lee June
C/O MYOKARDIA, INC.
333 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
EVP, Chief Development Officer
Common Stock
2019-09-19
4
M
0
5435
11.95
A
10014
D
Common Stock
2019-09-19
4
S
0
5435
57.0844
D
4579
D
Stock Option (Right to Buy)
11.95
2019-09-19
4
M
0
5435
0.00
D
2027-01-31
Common Stock
5435
128242
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person.
Represents the weighted average sale price of the shares sold ranging from $57.00 to $57.22 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
/s/ Cynthia Ladd, as Attorney-in-Fact
2019-09-20